Circassia Group Plc Stock Performance
| CSSPF Stock | USD 0.92 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Circassia Group are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Circassia Group Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Circassia Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Quick Ratio | 1.40 | |
| Fifty Two Week Low | 0.2200 | |
| Fifty Two Week High | 0.7469 |
Circassia |
Circassia Group Relative Risk vs. Return Landscape
If you would invest 92.00 in Circassia Group Plc on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Circassia Group Plc or generate 0.0% return on investment over 90 days. Circassia Group Plc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Circassia, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Circassia Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Circassia Group's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Circassia Group Plc, and traders can use it to determine the average amount a Circassia Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CSSPF |
Based on monthly moving average Circassia Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Circassia Group by adding Circassia Group to a well-diversified portfolio.
Circassia Group Fundamentals Growth
Circassia OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Circassia Group, and Circassia Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Circassia OTC Stock performance.
| Return On Equity | -27.89 | |||
| Return On Asset | -6.61 | |||
| Profit Margin | (60.52) % | |||
| Operating Margin | (41.33) % | |||
| Current Valuation | 186.53 M | |||
| Shares Outstanding | 333.47 M | |||
| Price To Earning | (1.95) X | |||
| Price To Book | 3.00 X | |||
| Price To Sales | 6.41 X | |||
| Revenue | 27.1 M | |||
| EBITDA | (6.8 M) | |||
| Cash And Equivalents | 11.3 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1.7 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | (5 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 368 M | |||
| Retained Earnings | (260 M) | |||
| Current Asset | 169 M | |||
| Current Liabilities | 23 M | |||
About Circassia Group Performance
By analyzing Circassia Group's fundamental ratios, stakeholders can gain valuable insights into Circassia Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Circassia Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Circassia Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Circassia Pharmaceutical is traded on OTC Exchange in the United States.Things to note about Circassia Group Plc performance evaluation
Checking the ongoing alerts about Circassia Group for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Circassia Group Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Circassia Group Plc generated a negative expected return over the last 90 days | |
| Circassia Group Plc has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 27.1 M. Net Loss for the year was (19.4 M) with profit before overhead, payroll, taxes, and interest of 16.3 M. | |
| Circassia Group Plc has accumulated about 11.3 M in cash with (5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 60.0% of the company shares are held by company insiders |
- Analyzing Circassia Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Circassia Group's stock is overvalued or undervalued compared to its peers.
- Examining Circassia Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Circassia Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Circassia Group's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Circassia Group's otc stock. These opinions can provide insight into Circassia Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Circassia OTC Stock analysis
When running Circassia Group's price analysis, check to measure Circassia Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Circassia Group is operating at the current time. Most of Circassia Group's value examination focuses on studying past and present price action to predict the probability of Circassia Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Circassia Group's price. Additionally, you may evaluate how the addition of Circassia Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |